Cyriac Roeding

Cyriac Roeding is an American-German serial entrepreneur and investor in Silicon Valley focused on the intersection of physical and digital worlds. Earli is his fourth company, a BioAI firm that turns cancer cells against themselves with intravenously injected genetic switches that only activate in cancer cells and reprogram them to activate the immune system against themselves. It raised $104M from a16z, Khosla, Perceptive, Alex Gorsky (former CEO J&J) and others. Its SAB includes Jim Allison (Nobel Laureate) and Bob Langer.
‍

Roeding’s prior startup Shopkick was acquired for $250M, producing an 11x return for lead investor KleinerPerkins.

‍
He is invested in >20 startups including OpenAI and VC funds (a16z, Founders Fund, Greylock). Cyriac sold his first computer program in Germany at age 15, coded for HP during high school, and studied Japanese Management in Tokyo. At 25 at McKinsey, he co-authored the Harvard Business Press book Secrets-of-Software-Success. The WorldEconomicForum named him Global Innovator.